{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:19:38Z","timestamp":1768000778639,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hoc.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:16:20Z","timestamp":1668550580000},"page":"1125-1135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care"],"prefix":"10.1016","volume":"36","author":[{"given":"Alecia","family":"Nero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Bozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.hoc.2022.07.013_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"10091","key":"10.1016\/j.hoc.2022.07.013_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2022.07.013_bib3","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hoc.2022.07.013_bib4","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","volume":"6","author":"Herrick","year":"1910","journal-title":"Arch Intern Med"},{"issue":"2865","key":"10.1016\/j.hoc.2022.07.013_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia, a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"10.1016\/j.hoc.2022.07.013_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcmd.2018.05.001","article-title":"Biomarker signatures of sickle cell disease severity","volume":"72","author":"Du","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.013_bib7","doi-asserted-by":"crossref","first-page":"e201737","DOI":"10.1001\/jamanetworkopen.2020.1737","article-title":"Comparison of US federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity","volume":"3","author":"Farooq","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.013_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/003335491312800206","article-title":"Mortality rates and age at death from sickle cell disease: U.S., 1979-2005","volume":"128","author":"Lanzkron","year":"2013","journal-title":"Public Health Rep"},{"issue":"23","key":"10.1016\/j.hoc.2022.07.013_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hoc.2022.07.013_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words - racism and sickle cell disease","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.013_bib11","first-page":"1121","article-title":"The economic burden of end-organ damage among medicaid patients with sickle cell disease in the United States: A population-based longitudinal claims study","volume":"26","author":"Campbell","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.013_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ajh.26063","article-title":"Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)","volume":"96","author":"Osunkwo","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.013_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing health care disparities in sickle cell disease: A review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.013_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2022.07.013_bib17","author":"Services Administration"},{"key":"10.1016\/j.hoc.2022.07.013_bib19","year":"2020"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.013_bib20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999- 2009)","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.013_bib21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/pbc.24110","article-title":"Comprehensive care for sickle cell disease immigrant patients: a reproducible model achieving high adherence to minimum standards of care","volume":"59","author":"Colombatti","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.013_bib22","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: Defining models of care, essential components, and economic aspects","volume":"16","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.013_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.14423\/SMJ.0000000000000519","article-title":"Need for Specialized Centers to Provide Acute Care to Adults with Sickle Cell Disease","volume":"109","author":"Lanzkron","year":"2016","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.hoc.2022.07.013_bib24","doi-asserted-by":"crossref","first-page":"601.e9-15","DOI":"10.1016\/j.amjmed.2016.12.010","article-title":"Risk factors for 30-day readmission in adults with sickle cell disease","volume":"130","author":"Brodsky","year":"2017","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.hoc.2022.07.013_bib25","doi-asserted-by":"crossref","first-page":"e0236360","DOI":"10.1371\/journal.pone.0236360","article-title":"Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell program","volume":"15","author":"Rousseau","year":"2020","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.hoc.2022.07.013_bib26","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.013_bib27","doi-asserted-by":"crossref","first-page":"e28275","DOI":"10.1002\/pbc.28275","article-title":"A\u00a0patient-centered medical home model for comprehensive sickle cell care in infants and young children","volume":"67","author":"Barriteau","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.013_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.013_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.10757","article-title":"Effectiveness of a dedicated day hospital for management of acute sickle cell pain","volume":"92","author":"Adewoye","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.013_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"Kauf","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2022.07.013_bib31","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jval.2018.07.826","article-title":"The Economic Burden of Sickle Cell Disease in the United States","volume":"21","author":"Huo","year":"2018","journal-title":"Value in Health"},{"issue":"4","key":"10.1016\/j.hoc.2022.07.013_bib33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pbc.22069","article-title":"Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States","volume":"53","author":"Mvundura","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2022.07.013_bib34","first-page":"1345","article-title":"Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers","volume":"23","author":"Shah","year":"2020","journal-title":"J\u00a0Med Econ"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.013_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.23912","article-title":"Intensive management of high-utilizing adults with sickle cell disease lowers admissions","volume":"90","author":"Koch","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.013_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s40615-015-0142-7","article-title":"Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality","volume":"3","author":"Andemariam","year":"2016","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"issue":"11","key":"10.1016\/j.hoc.2022.07.013_bib37","first-page":"1009","article-title":"Caring for the adult with sickle cell disease: results of a multidisciplinary pilot program","volume":"102","author":"Artz","year":"2010","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.013_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5055\/jom.2017.0382","article-title":"Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease","volume":"13","author":"Mager","year":"2017","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.hoc.2022.07.013_bib39","first-page":"4","article-title":"The cost-benefit from the perspective of the hospital of a proactive psychiatric consultation service on inpatient general medicine services","volume":"2","author":"Sledge","year":"2016","journal-title":"Health Econ Outcome Res Open Access"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.013_bib40","first-page":"213","article-title":"Emergency Department (ED) overcrowding: evidence-based answers to frequently asked questions","volume":"28","author":"Salway","year":"2017","journal-title":"Rev M\u00e9d Cl\u00edn Condes"},{"issue":"10","key":"10.1016\/j.hoc.2022.07.013_bib41","first-page":"615","article-title":"Creating a medical home through the 340B drug pricing program","volume":"74","author":"Genao","year":"2010","journal-title":"Conn Med"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.013_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/HCM.0000000000000220","article-title":"Examining the benefits of the 340b drug discount program","volume":"37","author":"Gerlach","year":"2018","journal-title":"Health Care Manag (Frederick)"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.013_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1475-6773.13281","article-title":"The unintended consequences of the 340B safety-net drug discount program","volume":"55","author":"Thomas","year":"2020","journal-title":"Health Serv Res"},{"issue":"9","key":"10.1016\/j.hoc.2022.07.013_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s10995-018-2545-7","article-title":"Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States","volume":"22","author":"Malouin","year":"2018","journal-title":"Matern Child Health J"},{"issue":"2","key":"10.1016\/j.hoc.2022.07.013_bib45","first-page":"80","article-title":"Financial toxicity, Part I: a new name for a growing problem","volume":"27","author":"Zafar","year":"2013","journal-title":"Oncology (Williston Park)"},{"issue":"19","key":"10.1016\/j.hoc.2022.07.013_bib46","doi-asserted-by":"crossref","first-page":"e017793","DOI":"10.1161\/JAHA.120.017793","article-title":"Financial toxicity in atherosclerotic Cardiovascular disease in the United States: current state and future directions","volume":"9","author":"Khera","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.hoc.2022.07.013_bib47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/SLA.0000000000004201","article-title":"The increasing financial burden of outpatient elective surgery for the privately insured","volume":"272","author":"Billig","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2022.07.013_bib48","series-title":"Kaiser health news","article-title":"Her Doctor\u2019s Office Moved One Floor Up. Her Bill Was 10 Times Higher","author":"Weber","year":"2021"},{"key":"10.1016\/j.hoc.2022.07.013_bib49","unstructured":"Yale New Haven Health. What are facility fees, and why do we have them? In:The Bulletin. 2018. Available at: https:\/\/www.ynhhs.org\/publications\/bulletin\/051718\/what- are-facility-fees-and-why-do-we-have-them. Accessed May 17, 2018."},{"key":"10.1016\/j.hoc.2022.07.013_bib50","unstructured":"State of CT Substitute Senate Bill No. 683 Public Act No. 21-129 AN ACT CONCERNING HOSPITAL BILLING AND COLLECTION EFFORTS BY HOSPITALS AND COLLECTION AGENCIES. (Effective October 1, 2022) https:\/\/www.cga.ct.gov\/2021\/ACT\/PA\/PDF\/2021PA-00129-R00SB-00683-PA.PDF."},{"key":"10.1016\/j.hoc.2022.07.013_bib51","series-title":"Kaiser health news","article-title":"\u2018The Charges Seem Crazy\u2019: Hospitals Impose a \u2018Facility Fee\u2019 - For a Video Visit","author":"Andrews","year":"2021"},{"key":"10.1016\/j.hoc.2022.07.013_bib52","unstructured":"Kamal R, Cox C, McDermott D. What are the recent and forecasted trends in prescriptiondrug spending? In:Peterson-KFF Health System Tracker. 2018. Available at: https:\/\/www.healthsystemtracker.org\/chart-collection\/recent-forecasted-trendsprescription-drug-spending\/#item-percent-of-total-rx-spending-by-oop-privateinsurance- and-medicare_nhe-projections-2018-27. Accessed February 17, 2022."},{"issue":"1","key":"10.1016\/j.hoc.2022.07.013_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1468-0009.12171","article-title":"Big Pharma Profits and the Public Loses","volume":"94","author":"DeAngelis","year":"2016","journal-title":"Milbank Q"},{"issue":"12","key":"10.1016\/j.hoc.2022.07.013_bib54","doi-asserted-by":"crossref","first-page":"e2028510","DOI":"10.1001\/jamanetworkopen.2020.28510","article-title":"Changes in Drug List Prices and Amounts Paid by Patients and Insurers","volume":"3","author":"Yang","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.hoc.2022.07.013_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41408-020-0338-x","article-title":"The high cost of prescription drugs: causes and solutions","volume":"10","author":"Vincent Rajkumar","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.hoc.2022.07.013_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/16078454.2018.1549801","article-title":"Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study","volume":"24","author":"Cronin","year":"2019","journal-title":"Hematology"},{"issue":"26","key":"10.1016\/j.hoc.2022.07.013_bib59","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2022.07.013_bib60","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jval.2021.02.014","article-title":"Indirect economic burden of sickle cell disease","volume":"24","author":"Holdford","year":"2021","journal-title":"Value Health"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:18:10Z","timestamp":1760185090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0889858822000831"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.07.013","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}